Experimed

GÖNDERBİLGİ
EnglishTürkçe

Editoryal


DOI :10.26650/experimed.1404013   IUP :10.26650/experimed.1404013    Tam Metin (PDF)

Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept

Tungki Pratama Umar


PDF Görünüm

Referanslar

  • Roma-Rodrigues C, Rivas-Garaa L, Baptista PV, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 2020; 12(3): 233. google scholar
  • Rao K. CRISPR-Cas13 and its applications in human therapeutics. J High Sch Sci 2021; 5(4): 1-21. google scholar
  • Granados-Riveron JT, Aquino-Jarquin G. CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 2018; 78(15): 4107-13. google scholar
  • Gao J, Luo T, Lin N, Zhang S, Wang J. A new tool for CRISPR-Cas13a-based cancer gene therapy. Mol Ther Oncolytics 2020; 19: 79-92. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Umar, T.P. (2024). Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed, 14(1), 61-62. https://doi.org/10.26650/experimed.1404013


AMA

Umar T P. Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed. 2024;14(1):61-62. https://doi.org/10.26650/experimed.1404013


ABNT

Umar, T.P. Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed, [Publisher Location], v. 14, n. 1, p. 61-62, 2024.


Chicago: Author-Date Style

Umar, Tungki Pratama,. 2024. “Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept.” Experimed 14, no. 1: 61-62. https://doi.org/10.26650/experimed.1404013


Chicago: Humanities Style

Umar, Tungki Pratama,. “Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept.” Experimed 14, no. 1 (Dec. 2024): 61-62. https://doi.org/10.26650/experimed.1404013


Harvard: Australian Style

Umar, TP 2024, 'Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept', Experimed, vol. 14, no. 1, pp. 61-62, viewed 22 Dec. 2024, https://doi.org/10.26650/experimed.1404013


Harvard: Author-Date Style

Umar, T.P. (2024) ‘Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept’, Experimed, 14(1), pp. 61-62. https://doi.org/10.26650/experimed.1404013 (22 Dec. 2024).


MLA

Umar, Tungki Pratama,. “Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept.” Experimed, vol. 14, no. 1, 2024, pp. 61-62. [Database Container], https://doi.org/10.26650/experimed.1404013


Vancouver

Umar TP. Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept. Experimed [Internet]. 22 Dec. 2024 [cited 22 Dec. 2024];14(1):61-62. Available from: https://doi.org/10.26650/experimed.1404013 doi: 10.26650/experimed.1404013


ISNAD

Umar, TungkiPratama. “Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept”. Experimed 14/1 (Dec. 2024): 61-62. https://doi.org/10.26650/experimed.1404013



ZAMAN ÇİZELGESİ


Gönderim12.12.2023
Kabul05.02.2024
Çevrimiçi Yayınlanma25.03.2024

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.